Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
Leukemia
.
2022 Apr;36(4):1180-1184.
doi: 10.1038/s41375-021-01497-7.
Epub 2022 Jan 6.
Authors
Sriram Ravichandran
1
,
Steven Law
1
,
Shameem Mahmood
1
,
Brenden Wisniowski
1
,
Darren Foard
1
,
Marianna Fontana
1
,
Ana Martinez-Naharro
1
,
Carol Whelan
1
,
Julian D Gillmore
1
,
Helen J Lachmann
1
,
Philip N Hawkins
1
,
Ashutosh D Wechalekar
2
Affiliations
1
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
2
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
[email protected]
.
PMID:
34987193
PMCID:
PMC8979816
DOI:
10.1038/s41375-021-01497-7
No abstract available
Publication types
Letter
MeSH terms
Amyloidosis* / diagnosis
Humans
Immunoglobulin Light Chains
Immunoglobulin Light-chain Amyloidosis* / diagnosis
Prognosis
Recurrence
Substances
Immunoglobulin Light Chains
Grants and funding
FS/18/21/33447/BHF_/British Heart Foundation/United Kingdom